SCHEMBL3481392

SCHEMBL3481392

O=C1OC2(c3ccc(Cl)cc3Oc3cc(Cl)ccc32)c2cc(Br)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 8/20 0.50
MAPT P10636 3/20 0.50
MEN1 O00255 2/20 0.50
HTT P42858 2/20 0.50
KMT2A Q03164 2/20 0.50
PRMT1 Q99873 2/20 0.50
HPGD P15428 2/20 0.50
CYP2C19 P33261 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
SMAD3 P84022 1/20 0.50
ACE2 Q9BYF1 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CYP3A4 P08684 1/20 0.44
LMNA P02545 2/20 0.43
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
GSTP1 P09211 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3481609 0.90 FTO (0.55) FTOMAPTMEN1HTTKMT2A
SCHEMBL22191880 0.85 FTO (0.71) FTOMAPTMEN1HTTKMT2A
SCHEMBL5517802 0.84 FTO (0.58) FTOMAPTMEN1HTTKMT2A
SCHEMBL1207502 0.82 FTO (0.71) FTOMAPTMEN1HTTKMT2A
SCHEMBL31018343 0.82 FTO (0.67) FTOMAPTMEN1HTTKMT2A
SCHEMBL31018342 0.82 GSTP1 (0.54) FTOMAPTMEN1HTTKMT2A
SCHEMBL1209316 0.81 FTO (0.50) FTOMAPTMEN1HTTKMT2A
SCHEMBL13329826 0.81 FTO (0.69) FTOMAPTMEN1HTTKMT2A
SCHEMBL31159639 0.81 FTO (0.69) FTOMAPTMEN1HTTKMT2A
SCHEMBL9903940 0.80 FTO (0.68) FTOMAPTMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163910-B2 Amide-substituted xanthene dyes ELITECH HOLDING B.V. (NL) 2012-04-24 US disclosed
US-20090093612-A1 AMIDE-SUBSTITUTED XANTHENE DYES EPOCH BIOSCIENCES, INC. (US) 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093612-A1 AMIDE-SUBSTITUTED XANTHENE DYES ANXA5, PHOSPHO1, TPST2 FTO 1991/4885MAPT 1987/4885MEN1 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.